Moreover, adiponectin (Acrp30) treatment prevents DNA synthesis and cell proliferation in U87 and U251 glioma cell lines, thus resulting in arrest in the G1 phase of the cell cycle (32). This evidence concerns the gene ADIPOQ and central nervous system cancer.